BB's Stock Haven

[El Mago]

PLRS 4 days for the announcement TIME TO BUY !!!

Pluristem to Present Promising PLX Data for Additional Clinical Indications at Prestigious International Conference on Regenerative Medicine
Pluristem Life Systems, Inc. (OTCBB:PLRS) (DAX:PJT), a bio-therapeutics Company dedicated to the commercialization of non-personalized (allogeneic) cell therapy products for a variety of malignant, degenerative and auto-immune indications, announced today that it will present favorable results of pre-clinical studies of its proprietary PLacental eXpanded (PLX) cells for additional clinical indications on October 18th, at the “3rd World Congress on Regenerative Medicine” in Leipzig, Germany.

The Company previously announced that it had obtained favorable results in pre-clinical testing of PLX cells to treat limb ischemia, a potential market of over $1 Billion. PLX cells also showed in vitro to have properties that the Company believes gives these cells the potential to treat Parkinson's Disease.

Mr. Zami Aberman, Pluristem Chairman and CEO commented, “We are very proud that the Congress’ organizing committee found our research and studies valuable and chose Pluristem to present its findings at the Congress. We strongly believe that our PLX cells can be used to treat other diseases, such as central nervous system and cardiovascular disorders. We will soon submit the IND for our first product, PLX-I, for the treatment of blood cancers, to begin clinical trials early next year in the USA.”